Lung cancer is the most common and fatal malignant disease worldwide and has the
highest mortality rate among tumor-related causes of death. Early diagnosis and precision …

Lung cancer is considered one of the most fatal malignant neoplasms because of its late
detection. Detecting molecular markers in samples from routine bronchoscopy, including …

Liquid biopsy, which analyzes biological fluids especially blood specimen to detect and
quantify circulating cancer biomarkers, have been rapidly introduced and represents a …

Background Differentiating malignant lung tumors from benign pulmonary nodules is a great
challenge. While the analysis of bronchoalveolar lavage fluid (BALF) is used for diagnosing …

Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …

Liquid biopsy in lung cancer is evolving as an important added tool for screening, early
detection, monitoring, and even prognostication of lung cancer. Guidelines and expert …

Lung cancer is an exceedingly malignant tumor reported as having the highest morbidity
and mortality of any cancer worldwide, thus posing a great threat to global health. Despite …

Primary lung cancer is one of the most common malignant tumors in China. Approximately
60% of lung cancer patients have distant metastasis at the initial diagnosis, so it is …

Separation and detection of exfoliated tumor cells (ETCs) from bronchoalveolar lavage fluid
(BALF), namely the liquid biopsy of BALF, has been proved to be a valuable tool for the …

Abstract Purpose of Review Liquid biopsies have potential as tools for diagnosis, prognosis,
and prediction of response to therapy. Herein, we will extensively review four liquid …